Ali Khalifeh
Canadian Association of Cosmetic Dermatology and Surgery
Title: The comparative study on safety and effectiveness of restorative treatments for facial lipoatrophy associated with HIV
Biography
Biography: Ali Khalifeh
Abstract
Facial Lipoatrophy associated With HIV is one the worst adverse effects of HIV and antiviral treatments which not only impacts the quality of life by impairing self-esteem of the HIV infected patients but also is one the most complex challenges of the family members and the community to adjust with the patient’s social situation. rn Thymidine-based nucleoside analog cessation is the only proven treatment for HIV associated lipoatrophy, although plastic surgeons and dermatologists are constantly exploring the new horizons of cosmetic procedures to restore the lost fat and maintain the normal and natural look of the HIV-infected patients.rnAutologous Fat Transfer, biodegradable or permanent injectable fillers and facial prosthetics have been used for HIV facial lipoatrophy treatment and all have offered some acceptable safety and aesthetic results, but apparently there are not sufficient clinical studies in treatment of choice in facial lipoatrophy for HIV-infected patients.rnIn this article we discuss the comparative efficacy of different therapies, assessment of existence and severity of facial lipoatrophy, and treatment measures of various cosmetic procedures for HIV associated facial lipoatrophy. rn